258 filings
Page 5 of 13
8-K
d7ftjal yeg
6 Nov 19
Acceleron Reports Third Quarter 2019 Operating and Financial Results
7:54am
8-K
lr4s z6be5v0ebcr5
16 Sep 19
Acceleron Announces Topline Results from the Phase 2 Trial of ACE-083 in Patients with Facioscapulohumeral Muscular Dystrophy
5:12pm
8-K
cgyqbm9
5 Aug 19
Acceleron Reports Second Quarter 2019 Operating and Financial Results
4:09pm
CT ORDER
qphvgvmbm7c53 rh
5 Jul 19
Confidential treatment order
9:51am
8-K
c7mwtq nfwc25d9o
10 Jun 19
Departure of Directors or Certain Officers
4:47pm
8-K
1jvesp2
7 Jun 19
Other Events
4:06pm
8-K
kqy7bg4k kbt6igov9
9 May 19
Acceleron Reports First Quarter 2019 Operating and Financial Results
4:09pm
DEFA14A
5am1b3o fh
12 Apr 19
Additional proxy soliciting materials
4:22pm
8-K
7pyqzn f0
5 Apr 19
Acceleron Discontinues Development of Phase 1 Molecule ACE-2494
5:19pm
S-8
rd6lwvtdl yplfc20uj
27 Feb 19
Registration of securities for employees
4:28pm
8-K
tv1ke
27 Feb 19
Acceleron Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
4:12pm
424B2
xrjcogha8tjg8bm
17 Jan 19
Prospectus for primary offering
12:00am
8-K
s38qsg5ytr3
17 Jan 19
Other Events
12:00am
424B5
y4g5gg1 w4
14 Jan 19
Prospectus supplement for primary offering
5:29pm
8-K
41v1p9kw fc68e4r
7 Jan 19
Regulation FD Disclosure
7:17am
8-K
h8nvz9gy
3 Dec 18
Regulation FD Disclosure
8:34am